William Blair initiated research coverage of Century Therapeutics, Inc. (IPSC $9.04), a biotechnology company focused on developing allogeneic iPSC-derived cellular immunotherapies, including CAR-NK and CAR-T cell therapies, for the treatment of cancer. Analyst Sami Corwin, Ph.D., said that induced pluripotent stem cells, or iPSCs, have the potential to be a […]

CHICAGO & NEW YORK, January 06, 2022–(BUSINESS WIRE)–William Blair, the premier global boutique with expertise in investment banking, investment management, and private wealth management, today announced that Scott McLaughlin has been named head of equities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220106005617/en/ Scott McLaughlin (Photo: Business […]

CHICAGO, January 13, 2022–(BUSINESS WIRE)–William Blair, the premier global boutique with expertise in investment banking, investment management, and private wealth management, announced that Brent Gledhill, the firm’s president, has been elected chief executive officer, succeeding John Ettelson, who has been appointed William Blair’s chairman. This press release features multimedia. View […]